Spots Global Cancer Trial Database for mutation analysis
Every month we try and update this database with for mutation analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biomarkers in Patients With Head and Neck Cancer | NCT01466257 | Head and Neck C... | cetuximab cisplatin DNA analysis gene expression... mutation analys... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C | NCT00040729 | Unspecified Adu... | mutation analys... | 18 Years - | National Cancer Institute (NCI) | |
| Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor | NCT01314391 | Kidney Cancer Renal Failure | mutation analys... polymerase chai... laboratory biom... | - 15 Years | Children's Oncology Group | |
| Irinotecan in Treating Patients With Colorectal Cancer | NCT00003843 | Colorectal Canc... | irinotecan hydr... mutation analys... polymorphism an... | 18 Years - | California Cancer Consortium | |
| Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia | NCT00003291 | Leukemia | cytogenetic ana... mutation analys... laboratory biom... | - 17 Years | Children's Oncology Group | |
| Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy | NCT00002924 | Prostate Cancer | mutation analys... | - | Alliance for Clinical Trials in Oncology | |
| Biomarkers in Blood Samples From Patients With Refractory Non-Small Cell Lung Cancer Previously Treated With Sorafenib Tosylate | NCT01124669 | Lung Cancer | DNA analysis mutation analys... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy | NCT00048971 | Colorectal Canc... Diarrhea Neutropenia | mutation analys... polymorphic mic... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin | NCT01503541 | Leukemia | DNA analysis RNA analysis gene expression... mutation analys... polymerase chai... laboratory biom... | 18 Years - 88 Years | SWOG Cancer Research Network | |
| Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors | NCT02215928 | Unspecified Adu... | mutation analys... cytology specim... laboratory biom... | 18 Years - | Stanford University | |
| Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer | NCT00628368 | Colorectal Canc... Esophageal Canc... | gene expression... mutation analys... polymorphism an... laboratory biom... biopsy endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Studying Genes in Samples From Younger Patients With Desmoplastic Small Round Cell Tumor Registered on COG-D9902 or COG-ABTR01B1 | NCT01430637 | Sarcoma | DNA analysis RNA analysis gene expression... mutation analys... nucleic acid se... polymerase chai... laboratory biom... pharmacogenomic... | - 50 Years | Children's Oncology Group | |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | NCT01234935 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem... | 18 Years - | Translational Oncology Research International | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer | NCT00898664 | Head and Neck C... | cytogenetic ana... gene expression... mutation analys... polymerase chai... immunohistochem... laboratory biom... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer | NCT00766454 | Breast Cancer | DNA analysis mutation analys... polymorphism an... laboratory biom... medical chart r... questionnaire a... evaluation of c... | - 120 Years | Wake Forest University Health Sciences | |
| Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer | NCT00004210 | Colorectal Canc... | loss of heteroz... microsatellite ... mutation analys... counseling inte... | 18 Years - | National Cancer Institute (NCI) | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT01259089 | Adenocarcinoma ... Non-small Cell ... | erlotinib hydro... Hsp90 inhibitor... laboratory biom... needle biopsy mutation analys... pharmacological... | 18 Years - | Northwestern University | |
| Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00390403 | Brain and Centr... | R-(-)-gossypol ... temozolomide gene expression... mutation analys... protein express... laboratory biom... pharmacological... adjuvant therap... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes | NCT00454480 | Leukemia Myelodysplastic... | alemtuzumab arsenic trioxid... azacitidine busulfan clofarabine cytarabine daunorubicin hy... fludarabine pho... gemtuzumab ozog... melphalan tipifarnib DNA methylation... cytogenetic ana... gene expression... mutation analys... diagnostic labo... immunologic tec... allogeneic hema... nonmyeloablativ... | - | National Cancer Institute (NCI) | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT00499655 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | erlotinib hydro... celecoxib placebo laboratory biom... immunohistochem... fluorescence in... mutation analys... protein express... gene expression... | 18 Years - | City of Hope Medical Center | |
| DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia | NCT00899366 | Leukemia | microarray anal... mutation analys... immunologic tec... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal Cancer | NCT01126450 | Colon Cancer Rectal Cancer | lenalidomide cetuximab mutation analys... polymerase chai... polymorphism an... | 18 Years - | Case Comprehensive Cancer Center | |
| Study of a Polymorphism in Patients With Prostate Cancer | NCT00900185 | Prostate Cancer | mutation analys... polymerase chai... polymorphism an... | - | National Cancer Institute (NCI) | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 | NCT00897351 | Prostate Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Study of Biomarkers in Tissue Samples From Patients With Breast Cancer | NCT01004796 | Breast Cancer | cytogenetic ana... microarray anal... mutation analys... immunohistochem... immunologic tec... mass spectromet... | - 120 Years | National Cancer Institute (NCI) | |
| Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia | NCT01385150 | Leukemia | mutation analys... protein analysi... laboratory biom... liquid chromato... mass spectromet... | 17 Years - 60 Years | Eastern Cooperative Oncology Group | |
| Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome | NCT00075348 | Kidney Cancer Von Hippel-lind... | mutation analys... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia | NCT01284010 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymerase chai... laboratory biom... | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma | NCT00617799 | Kidney Cancer Melanoma (Skin) | aldesleukin gene expression... mutation analys... flow cytometry | 19 Years - 120 Years | University of Nebraska | |
| DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE | NCT00900536 | Kidney Cancer | mutation analys... polymorphism an... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia | NCT01269385 | B-cell Chronic ... Refractory Chro... Stage 0 Chronic... Stage I Chronic... Stage II Chroni... | alemtuzumab rituximab PGG beta-glucan flow cytometry laboratory biom... DNA analysis fluorescence in... polymerase chai... polymorphism an... mutation analys... | 18 Years - | Mayo Clinic | |
| Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507 | NCT00907699 | Lung Cancer | DNA analysis RNA analysis fluorescence in... gene expression... mutation analys... polymerase chai... reverse transcr... laboratory biom... | 18 Years - | Case Comprehensive Cancer Center | |
| Positron Emission Tomography in Women With Advanced HER2-Positive Breast Cancer | NCT01093612 | Breast Cancer Stage IV Breast... | positron emissi... copper Cu 64-DO... Biopsy Immunohistochem... laboratory biom... mutation analys... | 18 Years - | City of Hope Medical Center | |
| A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | NCT01131429 | Neoplasms, Lung Carcinoma, Non-... Drug Therapy Genes, EGFR | Erlotinib Docetaxel Cisplatin Docetaxel Cisplatin Erlotinib | 18 Years - | Chinese PLA General Hospital | |
| Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia | NCT00003291 | Leukemia | cytogenetic ana... mutation analys... laboratory biom... | - 17 Years | Children's Oncology Group | |
| Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery | NCT01234935 | Acinar Cell Ade... Duct Cell Adeno... Recurrent Pancr... Stage IA Pancre... Stage IB Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | dasatinib gemcitabine hyd... laboratory biom... mutation analys... nucleic acid se... immunohistochem... | 18 Years - | Translational Oncology Research International | |
| Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer | NCT00482872 | Head and Neck C... | gene expression... mutation analys... polymerase chai... polymorphism an... flow cytometry laboratory biom... | 18 Years - 120 Years | Vanderbilt University Medical Center | |
| Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT00499655 | Recurrent Non-s... Stage IIIB Non-... Stage IV Non-sm... | erlotinib hydro... celecoxib placebo laboratory biom... immunohistochem... fluorescence in... mutation analys... protein express... gene expression... | 18 Years - | City of Hope Medical Center | |
| Biomarkers in Samples From Young Patients With Soft Tissue Sarcoma | NCT01342783 | Sarcoma | DNA analysis RNA analysis mutation analys... nucleic acid se... laboratory biom... | - 18 Years | Children's Oncology Group | |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01653613 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom... | 16 Years - 39 Years | National Cancer Institute (NCI) | |
| Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer | NCT00070278 | Breast Cancer | cyclophosphamid... epirubicin hydr... gemcitabine hyd... paclitaxel comparative gen... microarray anal... mutation analys... conventional su... neoadjuvant the... | - | National Cancer Institute (NCI) | |
| Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | NCT00346008 | Melanoma (Skin) | mutation analys... high performanc... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors | NCT00389805 | Lung Cancer Unspecified Adu... | bortezomib pemetrexed diso... gene expression... mutation analys... protein express... reverse transcr... flow cytometry immunoenzyme te... immunohistochem... | 18 Years - 120 Years | University of California, Davis | |
| Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer | NCT00467129 | Colorectal Canc... | microarray anal... mutation analys... polymerase chai... polymorphism an... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer | NCT01026337 | Renal Cell Carc... Stage III Renal... Stage IV Renal ... | mutation analys... pharmacological... dynamic contras... sunitinib malat... immunohistochem... laboratory biom... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia | NCT01251159 | Leukemia | mutation analys... polymerase chai... immunologic tec... laboratory biom... | 16 Years - 60 Years | Eastern Cooperative Oncology Group | |
| Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer | NCT00766454 | Breast Cancer | DNA analysis mutation analys... polymorphism an... laboratory biom... medical chart r... questionnaire a... evaluation of c... | - 120 Years | Wake Forest University Health Sciences | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer | NCT00551421 | Adenocarcinoma ... Adenocarcinoma ... Recurrent Colon... Recurrent Recta... Stage III Colon... Stage III Recta... Stage IV Colon ... Stage IV Rectal... | pertuzumab cetuximab irinotecan hydr... immunohistochem... fluorescence in... gene expression... mutation analys... polymerase chai... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy | NCT00801385 | Lung Cancer | erlotinib hydro... sorafenib tosyl... DNA analysis mutation analys... polymerase chai... protein analysi... protein express... immunohistochem... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Biomarkers in Young Patients With Neuroblastoma | NCT01169376 | Neuroblastoma | DNA analysis DNA methylation... RNA analysis comparative gen... mutation analys... polymorphism an... | - 30 Years | Children's Oncology Group | |
| Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy | NCT00509093 | Leukemia | imatinib mesyla... gene expression... mutation analys... polymerase chai... flow cytometry biopsy | 18 Years - | Case Comprehensive Cancer Center | |
| Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | NCT01280643 | Metastatic Colo... | fluorouracil leucovorin calc... oxaliplatin irinotecan hydr... bevacizumab cetuximab capecitabine mutation analys... gene expression... laboratory biom... immunohistochem... nucleic acid se... protein express... polymerase chai... DNA analysis | 18 Years - | Fox Chase Cancer Center | |
| Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer | NCT00897143 | Lung Cancer Metastatic Canc... | microarray anal... mutation analys... flow cytometry immunologic tec... | - | Case Comprehensive Cancer Center | |
| CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7 | NCT00812669 | Leukemia | pegfilgrastim rituximab cyclophosphamid... fludarabine pho... cytogenetic ana... fluorescence in... gene expression... mutation analys... protein express... flow cytometry laboratory biom... | 0 Years - 64 Years | Cancer Trials Ireland | |
| Biomarkers in Predicting Response to Cetuximab in Patients With Advanced Colorectal Cancer | NCT01243372 | Colorectal Canc... | mutation analys... laboratory biom... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members | NCT00346008 | Melanoma (Skin) | mutation analys... high performanc... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia | NCT00769327 | Leukemia | imatinib mesyla... nilotinib cytogenetic ana... fluorescence in... microarray anal... mutation analys... polymerase chai... polymorphism an... laboratory biom... | 18 Years - 120 Years | Gruppo Italiano Malattie EMatologiche dell'Adulto | |
| Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma | NCT00360854 | Brain and Centr... | erlotinib hydro... mutation analys... polymorphism an... laboratory biom... pharmacological... radiation thera... | 1 Year - 21 Years | National Cancer Institute (NCI) | |
| Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors | NCT01572467 | Childhood Germ ... Leydig Cell Tum... Ovarian Cancer | RNA analysis gene expression... mutation analys... reverse transcr... laboratory biom... medical chart r... | - 120 Years | Children's Oncology Group | |
| Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma | NCT00617799 | Kidney Cancer Melanoma (Skin) | aldesleukin gene expression... mutation analys... flow cytometry | 19 Years - 120 Years | University of Nebraska | |
| HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598 | NCT00896909 | Lung Cancer | gene expression... mutation analys... polymerase chai... diagnostic labo... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Cancer Genome Study Using Samples From Patients With Stage I or Stage II Non-Small Cell Lung Cancer Treated on Clinical Trial ACOSOG-Z0030 | NCT00899535 | Lung Cancer | DNA analysis RNA analysis microarray anal... mutation analys... polymorphism an... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma | NCT00811759 | Melanoma (Skin) | sorafenib tosyl... temozolomide gene expression... mutation analys... laboratory biom... pharmacological... biopsy | 18 Years - | National Cancer Institute (NCI) | |
| Studying Genes in Samples From Younger Patients With Acute Lymphoblastic Leukemia | NCT01653613 | Leukemia | DNA analysis fluorescence in... gene expression... microarray anal... mutation analys... polymorphism an... reverse transcr... laboratory biom... | 16 Years - 39 Years | National Cancer Institute (NCI) | |
| Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy Participants | NCT00899327 | Leukemia Myelodysplastic... | DNA methylation... RNA analysis cytogenetic ana... gene expression... mutation analys... polymerase chai... protein express... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT01259089 | Adenocarcinoma ... Non-small Cell ... | erlotinib hydro... Hsp90 inhibitor... laboratory biom... needle biopsy mutation analys... pharmacological... | 18 Years - | Northwestern University | |
| A Chinese Randomized Crossover Study of Erlotinib Versus Docetaxel/Cisplatin in Previously Untreated Stage IIIB/IV Lung Adenocarcinoma With EGFR Mutations | NCT01131429 | Neoplasms, Lung Carcinoma, Non-... Drug Therapy Genes, EGFR | Erlotinib Docetaxel Cisplatin Docetaxel Cisplatin Erlotinib | 18 Years - | Chinese PLA General Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
